Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma
Fibroblast Activation Protein (FAP)-specific Positron Emission Tomography (PET) has shown promising results in various cancers. This pilot study compares FAP-specific PET to MRI for treatment planning in 13 Glioblastoma patients. The resulting incongruent volumes could provide additional information...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
27 June 2020
|
| In: |
Radiotherapy and oncology
Year: 2020, Volume: 150, Pages: 159-163 |
| ISSN: | 1879-0887 |
| DOI: | 10.1016/j.radonc.2020.06.040 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.radonc.2020.06.040 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0167814020303650 |
| Author Notes: | Paul Windisch, Manuel Röhrich, Sebastian Regnery, Eric Tonndorf-Martini, Thomas Held, Kristin Lang, Denise Bernhardt, Stefan Rieken, Frederik Giesel, Uwe Haberkorn, Jürgen Debus, Sebastian Adeberg |
| Summary: | Fibroblast Activation Protein (FAP)-specific Positron Emission Tomography (PET) has shown promising results in various cancers. This pilot study compares FAP-specific PET to MRI for treatment planning in 13 Glioblastoma patients. The resulting incongruent volumes could provide additional information for radiotherapy or biopsy planning. |
|---|---|
| Item Description: | Gesehen am 07.05.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1879-0887 |
| DOI: | 10.1016/j.radonc.2020.06.040 |